Market Tracker

09/28 9:45am ET

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

36.83
BATS BZX Real-Time Price
As of 9:45am ET
 +0.11 / +0.30%
Today’s Change
19.59
Today|||52-Week Range
65.34
-40.53%
Year-to-Date
Ionis/Biogen Complete Nusinersen NDA Submission in U.S.
Sep 27 / Zacks.com - Paid Partner Content
3 Ways Ionis Pharmaceuticals, Inc. Is Beating the Competition
Sep 19 / MotleyFool.com - Paid Partner Content
3 Stocks That Could Make You Rich
Sep 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close36.72
Today’s open36.88
Day’s range36.44 - 36.99
Volume6,959
Average volume (3 months)2,782,690
Market cap$4.4B
Dividend yield--
Data as of 9:45am ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-44.49%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book22.01

Competitors

 Today’s
change
Today’s
% change
PTHNPatheon NV+0.06+0.20%
AGNPRAAllergan plc0.000.00%
ICPTIntercept Pharmaceut...-2.13-1.24%
ACADACADIA Pharmaceutica...-0.45-1.28%
Data as of 9:45am ET, 09/28/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.09
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts